ask="2.75"
ask_size="100"
average_daily_volume="270257"
bid="1.70"
bid_size="5000"
book_value="0.88"
change="+0.00"
change_from_200_day_moving_average="-1.42"
change_from_50_day_moving_average="-0.27"
change_from_52_week_high="-5.08"
change_From_52_week_low="0.02"
change_in_percent="+0.00%"
close="1.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.04"
ex_dividend_date="N/A"
float_shares="28175000"
high="1.85"
high_52_weeks="6.88"
last_trade_date="3/7/2017"
last_trade_price="1.80"
last_trade_size="811"
last_trade_time="4:00pm"
low="1.80"
low_52_weeks="1.77"
market_capitalization="55.11M"
moving_average_200_day="3.22"
moving_average_50_day="2.07"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="1.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-44.13%"
percent_change_from_50_day_moving_average="-13.08%"
percent_change_from_52_week_high="-73.84%"
percent_change_from_52_week_low="+1.41%"
previous_close="1.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.06"
price_per_sales="140.52"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="12.29"
stock_exchange="NCM"
symbol="TROV"
volume="118399"
weeks_range_52="1.77 - 6.88"
